Clinical Trial

Dexmedetomidine Wound Infiltration in Cesarean Section

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-12-21; most recent amendment 2025-03-16.
Status change: Active, Not Recruiting → Recruiting 2022-02-15
Status change: Recruiting → Active, Not Recruiting 2020-01-08
Status change: Not Yet Recruiting → Recruiting 2018-06-15
Trial Details
NCT Number NCT03382938
Lead Sponsor Attikon Hospital
Conditions Postoperative Pain
Enrollment 100 participants
Start Date 2019-08-23
Primary Completion 2025-12-20 (estimated)
Study Completion 2026-11-20 (estimated)
Updated on ClinicalTrials.gov 2025-03-19